Skip to main content
Clinical Trials/NCT04814914
NCT04814914
Completed
Not Applicable

An Observational Study to Evaluate the Presence of Symptoms After COVID-19 Infection in Patients Who Participated in K031-120 or K032-120 Study ("Long Hauler")

Kaleido Biosciences2 sites in 1 country333 target enrollmentMarch 25, 2021
ConditionsCOVID-19

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
COVID-19
Sponsor
Kaleido Biosciences
Enrollment
333
Locations
2
Primary Endpoint
Proportion of patients with persistent COVID-19 symptoms for at least 12-weeks post-randomization in K031-120 or K032-120 study.
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

This observational clinical study aims to evaluate the presence of symptoms of COVID-19 infection in patients who participated in K031-120 or K032-120 ("long hauler").

Registry
clinicaltrials.gov
Start Date
March 25, 2021
End Date
May 28, 2021
Last Updated
4 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Kaleido Biosciences
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Have consented to participate over the telephone
  • Have been randomized in either the K031-120 or K032-120 study

Exclusion Criteria

  • Have withdrawn consent from K031-120 or K032-120

Outcomes

Primary Outcomes

Proportion of patients with persistent COVID-19 symptoms for at least 12-weeks post-randomization in K031-120 or K032-120 study.

Time Frame: 12-weeks from randomization in K031-120 or K032-120

Study Sites (2)

Loading locations...

Similar Trials